Evaluation of room temperature stable recombinant activated factor VII during continuous infusion: product and microbiological stability over 24 hours

被引：0
|
作者：
Cooper, D. [1 ]
Christensen, A. [2 ]
Jensen, J. [2 ]
Nohr, A. [2 ]
机构：
[1] Novo Nordisk Inc, Princeton, NJ USA
[2] Novo Nordisk AS, DK-2820 Gentofte, Denmark
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 39 条
  • [1] Room-Temperature-Stable Recombinant Activated Coagulation Factor VII Recombinant: Chemical and Microbiologic Stability Over 24 Hours During Continuous In Vitro Infusion
    Christensen, Abeline
    Jensen, Jane T.
    Nohr, Anne Mette
    Cooper, David L.
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (12) : 1997 - 2001
  • [2] Continuous infusion of recombinant activated factor VII: stability in infusion pump systems
    Bonde, C
    Jensen, MB
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 : S103 - S105
  • [3] Experiences with continuous infusion of recombinant activated factor VII
    Schulman, S
    d'Oiron, R
    Martinowitz, U
    Pasi, J
    Briquel, ME
    Mauser-Bunschoten, E
    Morfini, M
    Ritchie, B
    Goudemand, J
    Lloyd, J
    McPherson, J
    Négrier, C
    Peerlinck, K
    Petrini, P
    Tusell, J
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 : S97 - S101
  • [4] Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency
    Jiménez-Yuste, V
    Villar, A
    Morado, M
    Canales, M
    Hernández, MC
    Sanjurjo, MJ
    Quintana, M
    Hernández-Navarro, F
    [J]. HAEMOPHILIA, 2000, 6 (05) : 588 - 590
  • [5] In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature
    Nedergaard, Hanne
    Vestergaard, Susanne
    Jensen, Pernille Theil
    Kristiansen, Morten Wagner
    Jensen, Michael Bech
    Ostergaard, Per B.
    Norsell, Tina
    Bjerre, Jens
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (07) : 1309 - 1315
  • [6] Stability of turoctocog alfa, a recombinant factor VIII product, during continuous infusion in vitro
    Kawasugi, K.
    Pollard, D.
    Nohr, A. M.
    Rasmussen, D. K. Normann
    Jensen, J. Taaftegaard
    Takeyama, M.
    [J]. HAEMOPHILIA, 2019, 25 : 48 - 48
  • [7] Continuous infusion of recombinant activated factor VII for caesarean section delivery in a patient with congenital factor VII deficiency
    Jimenez-Yuste, V
    Villar, A
    Morado, M
    Canales, M
    Gago, J
    Sanjurjo, MJ
    Quintana, M
    Magallon, M
    Hernandez-Navarrro, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 804 - 804
  • [8] Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency
    Miyata, Naoko
    Isaka, Mitsuhiro
    Kojima, Hideaki
    Maniwa, Tomohiro
    Takahashi, Shoji
    Takamiya, Osamu
    Ohde, Yasuhisa
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (03) : 177 - 180
  • [9] Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific region
    McPherson, J
    Sutcharitchan, P
    Lloyd, J
    Street, A
    Jorgensen, LN
    Yang, SI
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S31 - S34
  • [10] Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency
    Naoko Miyata
    Mitsuhiro Isaka
    Hideaki Kojima
    Tomohiro Maniwa
    Shoji Takahashi
    Osamu Takamiya
    Yasuhisa Ohde
    [J]. General Thoracic and Cardiovascular Surgery, 2016, 64 : 177 - 180
1234